Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 134

1.

Use of epoetin in chronic renal failure.

Coyne DW.

JAMA. 2007 Apr 18;297(15):1713-6. No abstract available.

PMID:
17440149
2.

Epoetin dosing and dialysis facility ownership.

Kliger AS, Nissenson AR.

JAMA. 2007 Aug 22;298(8):861-2; author reply 862-3. No abstract available.

PMID:
17712067
3.

Epoetin dosing and dialysis facility ownership.

Regidor DL, Kalantar-Zadeh K, Kovesdy CP.

JAMA. 2007 Aug 22;298(8):862; author reply 862-3. No abstract available.

PMID:
17712068
4.

Dialysis facility ownership and epoetin dosing in patients receiving hemodialysis.

Thamer M, Zhang Y, Kaufman J, Cotter D, Dong F, Hernán MA.

JAMA. 2007 Apr 18;297(15):1667-74.

PMID:
17440144
5.

Major declines in epoetin dosing after prospective payment system based on dialysis facility organizational status.

Thamer M, Zhang Y, Kaufman J, Kshirsagar O, Cotter D, Hernán MA.

Am J Nephrol. 2014;40(6):554-60. doi: 10.1159/000370334. Epub 2015 Jan 10.

6.

Regarding impact of epoetin alfa on clinical end points in patients with chronic renal failure: a meta-analysis.

Tonelli M, Owen WF Jr, Jindal K, Winkelmayer WC, Manns B.

Kidney Int. 2004 Oct;66(4):1712; author reply 1712-3. No abstract available.

7.

Use of Carnitor for Epogen resistant anemia.

Simard JC.

ANNA J. 1999 Feb;26(1):41-2.

PMID:
10222857
8.

Switching epoetin alfa and epoetin zeta in patients with renal anemia on dialysis: Posthoc analysis.

Więcek A, Ahmed I, Scigalla P, Koytchev R.

Adv Ther. 2010 Dec;27(12):941-52. doi: 10.1007/s12325-010-0080-z. Epub 2010 Oct 22.

PMID:
20972656
9.

Effects of Epoetin alfa on hemostasis in chronic renal failure.

Tang WW, Stead RA, Goodkin DA.

Am J Nephrol. 1998;18(4):263-73. Review.

PMID:
9653828
10.

Comparison of the therapeutic effects of epoetin zeta to epoetin alfa in the maintenance phase of renal anaemia treatment.

Wizemann V, Rutkowski B, Baldamus C, Scigalla P, Koytchev R; Epoetin Zeta Study Group.

Curr Med Res Opin. 2008 Mar;24(3):625-37. doi: 10.1185/030079908X273264. Erratum in: Curr Med Res Opin. 2008 Oct;24(10):3007. Curr Med Res Opin. 2008 Apr;24(4):1155.

PMID:
18208642
11.
12.

Therapeutic equivalence of epoetin zeta and alfa, administered subcutaneously, for maintenance treatment of renal anemia.

Krivoshiev S, Wizemann V, Czekalski S, Schiller A, Pljesa S, Wolf-Pflugmann M, Siebert-Weigel M, Koytchev R, Bronn A; Epoetin Zeta Study Group.

Adv Ther. 2010 Feb;27(2):105-17. doi: 10.1007/s12325-010-0012-y. Epub 2010 Mar 30.

PMID:
20369312
13.

Epoetin bubble: a severe German case Honi soit qui mal y pense.

Wizemann V.

Nephrol Dial Transplant. 2011 May;26(5):1750-2; author reply 1752. doi: 10.1093/ndt/gfr016. Epub 2011 Mar 4. No abstract available.

PMID:
21378149
14.

Relative mortality and epoetin alpha dose among hemodialysis patients.

Coyne DW.

Am J Kidney Dis. 2008 May;51(5):866-7; author reply 867. doi: 10.1053/j.ajkd.2008.01.028. No abstract available.

PMID:
18436101
15.

Relative mortality and epoetin alpha dose in hemodialysis patients.

Cotter DJ, Thamer M, Zhang Y.

Am J Kidney Dis. 2008 May;51(5):865; author reply 865-6. doi: 10.1053/j.ajkd.2007.12.045. No abstract available.

PMID:
18436099
16.

Impact of epoetin alfa on clinical end points in patients with chronic renal failure: a meta-analysis.

Jones M, Ibels L, Schenkel B, Zagari M.

Kidney Int. 2004 Mar;65(3):757-67.

17.

[Frequency of anaemia and indications for treatment with epoetin in chronic renal failure at the pre-dialysis stage].

Jungers PY, Nguyen-Khoa T, Joly D, Choukroun G, Massy ZA, Jungers P.

Presse Med. 2003 Feb 8;32(5):212-6. French.

PMID:
12610461
18.

Dialysis facility ownership and epoetin dosing in hemodialysis patients: an overview.

Weiner DE, Levey AS.

Am J Kidney Dis. 2007 Sep;50(3):349-53. No abstract available.

PMID:
17720511
19.

Anemia: What can we learn from a secondary analysis of CHOIR?

Hörl WH.

Nat Rev Nephrol. 2010 May;6(5):251-2. doi: 10.1038/nrneph.2010.22. No abstract available.

PMID:
20424625
20.

Management of the chronic renal failure patient receiving epoetin alfa for the treatment of anemia.

Binkley LS.

Transplant Proc. 1991 Apr;23(2):1831-2. Review. No abstract available.

PMID:
2053169

Supplemental Content

Support Center